SECURITIES AND EXCHANGE COMMISSION

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

January 13,2006

Via Facsimile and US Mail

Robert A. Graurnan

Baker & McKenzie

1114 Avenue of the Americas

New York, New York 10036

Re:

Conversion Offer by Fresenius Medical Care AG to Holders of its

Non-Voting Preference Shares

TP NO.06-24

Dear Mr. Graurnan:

This is in response to your letter to James A. Brigagliano, Mauri L. Osheroff, Brian V.

Breheny and Michael Pressman dated January 13,2006 as supplemented by telephone

conversations with the staff of the Divisions of Corporation Finance and Market

Regulation, with regard to your request for exemptive relief. A copy of your letter is

attached with this response. By including a copy of your correspondence, we avoid

having to repeat or summarize the facts you presented. The defined terms in this letter

have the same meaning as in your letter, unless otherwise noted.

The United States Securities and Exchange Commission (Commission) hereby grants an

exemption fiom Rule 14e-5 under the Securities Exchange Act of 1934 (Exchange Act)

on the basis of your representations and the facts presented, but without necessarily

concurring in your analysis. The exemption fiom Rule 14e-5 is to permit Fresenius

Medical Care AG to purchase or arrange to purchase FMC AG Preference Shares

pursuant to the German Offer during the U.S. Offer. You do not request, and we do not

grant, any relief regarding purchases or arrangements to purchase shares or ADSs other

than pursuant to the U.S. and German Offers.

Based on the representations in your January 13,2006 letter but without necessarily

concurring in your analysis, the Commission also hereby grants exemptions f?om:

Rule 13e-4(0(8)(i), to permit the U.S. Offer to be made available to all

holders of FMC AG Preference Share ADSs; and

/'-

/

Robert A. Grauman, Esq.

January 13,2006

Page 2

Rule 13e-4(0(6), to permit purchases of FMC AG Preference Shares pursuant

to the German Offer during the U.S Offer and the 10 business days following

the expiration of the U.S. Offer.

The foregoing exemptions are based solely on the representations and the facts presented

in your letter, as supplemented by telephone conversations with the staff. The relief is

strictly limited to the application of the rules listed above to this transaction. You should

discontinue t h s transaction pending further consultations with the staff if any of the facts

or representations set forth in your letter change.

We also direct your attention to the anti-fiaud and anti-manipulation provisions of the

federal securities laws, including Sections 14(e), lo@) of the Exchange Act, and Rule

lob-5 thereunder. The participants in this transaction must comply with these and any

other applicable provisions of the federal securities laws. The Divisions of Corporation

Finance and Market Regulation express no view on any other questions that may be

raised by the proposed transaction, including but not limited to, the adequacy of

disclosure concerning and the applicability of any other federal or state laws to the

proposed transaction.

For the Commission

By the Division of Corporation Finance

pursuant to delegated authority

For the Commission

By the Division of Market Regulation

pursuant to delegated authority

Mauri L. Osheroff

Associate Director, Regulatory Policy

Division of Corporation Finance

James A. Brigagliano

Assistant Director

Division of Market Regulation

Baker & McKenzie LLP

1114 Avenue of the Americas

New York, New York 10036, USA

Tel: +1 212 626 4100

Fax: +1 212 310 1600

www.bakernet.com

Asl.

Paclnc

Bangkok

Beijing

Hanoi

Ho Chi Minh Cily

Hong Kong

Jakarta

Kuala Lumpur

Manila

Melbourne

Shanghai

Singapom

Sydney

Taipei

Tokyo

Europe (L

Mlddle Last

Almaty

Amstenlam

Antwerp

Bahrain

Baku

Barcelona

Berlln

Bologna

Biussels

Budapest

Cairo

OOsseldorf

Frankfurt IMain

Geneva

Kyiv

London

Madrid

Milan

Moscow

Munich

Paris

Pragua

Rlyadh

Rome

St. Petenburg

Stockholm

Vienna

Warsaw

Zurich

North South

America

Bogou

Brasilia

Buenos Aires

Calgary

Caracas

Chlcago

Dallas

Guadalajara

Houslon

Juarez

Mexico Ci

Miami

Monterrey

New York

Palo Alto

Porlo Alegre

Rio de Janeim

San Diego

San Francisco

Santiago

Sao Paulo

Tijuana

Tomnto

Valencia

Washington. DC

January 13,2006

James A. Brigagliano, Esq.

Assistant Director

Securities and Exchange Commissiop

Division of Market Regulation

Office of Trading Practices

100 F Street NE

Washington DC 20549

Tel: +1 212 891 3587

Fax: +1 212 310 1687

Robert.A.Graurnan@Bakemet.com

Via Federal Express

Mauri L. Osheroff, Esq.

Associate Director

Brian V. Breheny, Esq.

Chief, Office of Mergers and Acquisitions

Michael Pressman, Esq.

Special Counsel, Ofice of Mergers and Acquisitions

Securities and Exchange Commission

Division of Corporation Finance

100 F Street NE

Washington DC 20549

RE:

Conversion Offer by Fresenius Medical Care AG to holders of its Non-Voting

Preference Shares, including Preference Shares Represented by ADSs

Our File No. 56176174-000003

Ladies and Gentlemen:

I am writing on behalf of our client, Fresenius Medical Care AG ("FMC-AG" or the

"Company"), a stock corporation (Aktiengesellschaft) organized under German law, in

connection with its offers (the "Conversion Offers") to the holders of its Non-Voting

Preference Shares of the opportunity to convert their Preference Shares into Ordinary Shares.

The Company filed a registration statement on Form F-4 with respect to the Conversion

Offers on October 7,2005, File No. 333-128899, with the Securities and Exchange

Commission (the "Commission"). The Company filed Amendment No. 1 to the Registration

Statement on November 17,2005 and Amendment No. 2 to the Registration Statement on

December 23,2005 (said registration statement, as amended to date and as it may be further

amended, the "Registration Statement"). The Registration Statement has not yet been

declared effective. The Company filed a Schedule TO on October 11,2005 (inadvertently

tagged as a Schedule TO-I) that incorporated the preliminary prospectus in the Registration

Statement, as originally filed, a pre-commencement Schedule TO-C that incorporated the

preliminary prospectus, as contained in Amendment No. 1 to the Registration Statement, on

November 17,2005 and a pre-commencement Schedule TO-C that incorporated the

Baker & McKenzie LLP is a member of Baker & McKenzie International, a Swiss Verein.

preliminary prospectus, as contained in Amendment No. 2 to the Registration Statement, on

December 23,2005. Amendment No. 3 to the Registration Statement was filed upon the

opening of the Edgar system on January 4,2006. Amendment No. 3 was filed solely to

place on file revised tax opinions dated January 4,2006, the effective date of the

Registration Statement, as requested in the comment letter dated October 24,2005 from

Michael Pressman, Esq., Special Counsel in the Office of Mergers and Acquisitions in the

Division of Corporation Finance.

1.

The Comuanv

The Company is a multinational "foreign private issueryy

within the meaning of Rule 3b-4(c)

- having its corporate seat in the Federal Republic of ~ e r m a n ~ The

. ' Company operates in the

fields of dialysis products and dialysis services. Based on publicly reported sales and number

of patients treated, the Company is the largest dialysis company in the world. (Source:

Nephrology News & Issues, July 2005; company data of significant competitors.) Its dialysis

business is vertically integrated, providing dialysis treatment at its own dialysis clinics and

supplying these clinics with a broad range of dialysis products. The Company also sells

dialysis products to other dialysis service providers. At September 30,2005, the Company

provided dialysis treatment to approximately 130,400 patients in 1,670 clinics worldwide

located in 27 countries. In the U.S., the Company also performs clinical laboratory testing

and provides inpatient dialysis services, therapeutic aphaeresis, hemopefision and other

services under contract to hospitals. In 2004 and the frst nine months of 2005, the Company

provided 18.8 million and 14.7 million dialysis treatments, respectively. The Company also

develops and manufactures a full range of equipment, systems and disposable products,

which it sells to customers in over 100 countries. For the year ended December 3 1,2004, the

Company had net revenues of $6.2 billion.

The Company has two classes of shares - Ordinary Shares and Preference Shares - listed on

the Frankfurt Stock Exchange and, in ADS form, on the New York Stock Exchange (the

'WSE") and registered pursuant to Section 12(b) of the Securities Exchange Act of 1934

(the "Exchange Acty'). The Company files annual reports on Form 20-F and interim reports

on Form 6-K. The Company is current in its filing obligations under the Exchange Act.

Subject to certain exceptions, the Ordinary Shares are the Company's sole voting shares.

2.

The Conversion Offers and the Transformation of Legal Form

A.

The Transformation of legal Form

On August 30,2005, the Company's shareholders approved a resolution for the

transformation of FMC-AG's legal form (the "Transformation") from a stock corporation

1

All information in this letter regarding the provisions and effects of German law has been

provided by Norr Stiefenhofer Lutz, the Company's German corporate counsel.

James A. Brigagliano, Esq

Mauri L. Osheroff, Esq.

Brian V. Breheny, Esq.

Michael Pressman, Esq.

January 13,2006

NYCDMS1969970.11

Page 2

(Aktiengesellschaf) under German law into a partnership limited by shares

(Komrnanditgesellschaft auf Aktien) under German law to be called Fresenius Medical Care

AG & Co. KGaA ("FMC-KGaA"). Upon registration of the Transformation with the

German Commercial Register, the share capital of FMC-AG will become the share capital of

FMC-KGaA, and shareholders in FMC-AG will become shareholders of FMC-KGaA. The

Company intends to arrange for the registration of the Transformation with the German

Commercial Register following completion of the Conversion Offers, and it wil not register

the Conversion of Preference Shares into Ordinary Shares pursuant to the Conversion Offers

unless it is satisfied that the Transformation of legal form will occur. Upon registration of

the transformation of legal form, the Company's Ordinary Shares will be transformed into

ordinary shares of FMC-KGaA. Accordingly, holders of FMC-AG Preference Shares

(including Preference Shares represented by ADSs) who elect to convert their shares in the

Conversion Offers will receive FMC-KGaA Ordinary Shares and holders of FMC-AG

Preference Shares (including Preference Shares represented by ADSs) who do not elect to

convert their shares in the Conversion Offers will become preference shareholders of FMCKGaA. The Company has applied to list the FMC-KGaA Ordinary Shares and Preference

Shares on the NYSE. Information regarding the Transformation is provided solely for

purposes of background, and we are not requesting any relief with respect to the

rans sf or mat ion?

B.

The Conversion Offers

Also on August 30,2005, holders of the Company's Ordinary Shares and Preference Shares

approved the Conversion and related amendments to its charter documents to permit the

conversion of Preference Shares into Ordinary Shares by eliminating the preferences held by

Preference Shares tendered for conversion. These amendments will become effective upon

filing with the German Commercial Register after completion of the Conversion Offers.

Only Preference Shares held by holders who accept the Conversion Offer will be converted;

remaining Preference Shares will retain their preferential rights.

Upon effectiveness of the Registration Statement, the Company will offer holders of its

Preference Shares resident in the United States, including Preference Shares represented by

ADSs (the "U.S. Offer"), the opportunity to convert their Preference Shares into Ordinary

Shares on the basis of one Ordinary Share for one Preference Share plus a conversion

premium of €9.75 per share. One Preference Share ADS and one Ordinary Share ADS

represent one-third of a Preference Share and one-third of an Ordinary Share, respectively,

and the conversion premium per ADS, therefore, will be €3.25. A separate Conversion

Offer (the "German Offer"), to be made pursuant to a prospectus approved by the German

* The offer and sale of FMC-KGaA Ordinary Shares and Preference Shares that may be deemed to

have occurred in connection with the Company's solicitation of shareholder approval for the

Transformation was separately registered on a Registration Statement on Form F-4 that was declared

effectiveby the Commission on July 20,2005 (Registration No. 333-124759).

James A. Brigagliano, Esq

Mauri L. Osheroff, Esq.

Brian V. Breheny, Esq.

Michael Pressman, Esq.

January 13,2006

NYCDMS1969970.11

Page 3

Federal Financial Supervisory Authority (the Bundesanstalt@ Finanzdienstleistungaufsicht

or "BaFin") will be open to holders of Preference Shares (other than Preference Shares

represented by ADSs) who are located in Germany and, if permitted pursuant to applicable

local laws and regulations, other locations outside the United States.

Together, the Conversion Offers are being made with respect to all issued and outstanding

FMC-AG Preference Shares, including Preference Shares represented by ADSs and

Preference Shares that are or may become issuable prior to the expiration of the Conversion

Offers due to the exercise of outstanding FMC-AG stock options. All offers of the

conversion privilege and all conversions made pursuant to the German Offer will be made

outside of the United States. The U.S. Offer is being made on terms at least as favorable as

those offered to preference shareholders under the German Offer, and completion of each of

the Conversion Offers is subject to the same conditions.

The Registration Statement relates to the registration under the Securities Act of 1933, as

amended, of up to 7,304,322~Ordinary Shares, including Ordinary Shares to be represented

by FMC-KGaA ADSs, to be outstanding in connection with the U.S. Offer. As indicated

above, the Ordinary Shares that will ultimately be issued upon completion of the Conversion

Offers and the Transformation will be FMC-KGaA Ordinary Shares. Both FMC-AG and

FMC-KGaA are co-registrants under the Registration Statement, and both are identified as

"issuers" on the Schedule TO filed by the

The U.S. Offer will be conducted as a ''Tier II" offer pursuant to the provisions of Rule 13e4(i) under the Securities and Exchange Act of 1934, as amended (the "Exchange Act"). To

facilitate the Conversion Offers, we hereby respectfully request that, with respect to the

Conversion Offers, that Staff grant exemptive relief fiom the provisions of the following

Rules under the Exchange Act:

As indicated in Part 3 below, the Company has identified 6,954,322 Preference Shares held in the

U.S. The additional registered shares are intended to take into account possible option exercises by

U.S. residents during the pendency of the Conversion Offers.

It should be noted that a new separate legal entity will not be created to effect the Transformation.

The Company will not, in connection with the Transformation, (i) transfer any assets to another entity,

(ii) merge into or with or consolidate with another entity, or (iii) acquire the shares of any other entity.

Rather, the transformation of the Company's legal form will become effective upon the filing with the

commercial register of the resolution approving the Transformation, and will occur as a matter of

German law, rather than as the result of an asset transfer or other separately identifiable transaction.

Upon consummation of the Conversion, the Company's legal form will be changed fiom a stock

corporation to a KGaA under German law. Under that law, the KGaA will be the same legal entity as,

rather than a successor to, the stock corporation. Accordingly, because the rans sf or mat ion has not yet

occurred, the Registration Statement and the Schedule TO were signed by the corporation that will be

the general partner of FMC-KGaA, on behalf of the KGaA to be formed upon the transformation of

legal form of FMC-AG.

James A. Brigagliano, Esq

Mauri L. Osheroff. Esq.

Brian V. Breheny. Esq.

Michael Pressman, Esq.

January 13,2006

NYCDMS1969970.11

Page 4

Rule 13e-4(f)(S)(i), to permit the U.S. Offer to extend to all holders of Preference

Share ADSs, wherever located;

* Rule 14e-5, to permit conversions of Preference Shares pursuant to the German

Offer; and

a

Rule 13e-4(%6), to permit conversions of Preference Shares pursuant to the German

Offer.

Qualification for Tier 11Relief'

3.

In separating the Conversion Offers into the U.S. Offer and the German Offer, and in

conducting the U.S. Offer on the terms described in this letter and the U.S. Prospectus, the

Company is relying on Rule 13e-4(i) under the Exchange Act, which provides relief fiom

certain otherwise applicable rules for issuers conducting issuer tender offers under certain

conditions. To qualify, holders of FMC-AG Preference Shares who are resident in the

United States ("US Holders") may not hold more than 40% of the outstanding FMC-AG

Preference Shares, including Preference Shares represented by FMC-AG Preference Share

ADSs.

FMC AGYsability to determine beneficial ownership of its Preference Shares is limited

because the shares are in bearer form. FMC-AG used the following procedures to confirm

its entitlement to Tier 11relief:

e

It has assumed (though not required to do so) that all Preference Shares represented

by ADSs (representing 763,506 preference shares) are held by U.S. Holders.

e

With the assistance of a shareholder communication consultant, FMC-AG has made

inquiries of banks, brokers and other fmancial intermediaries in Germany and the

United States and identified significant institutional and other major holders of its

Preference Shares.

The Company has 27,762,179 preference shares outstanding. The assumptions and efforts

described above have enabled FMC-AG to identify the holders of approximately 75% of its

outstanding Preference Shares, including one (non-US.) holder of 3,299,000 preference

shares (i.e., greater than 10% of the outstanding preference shares). Of its outstanding

preference shares, FMC-AG identified 6,954,322 shares as held by US. residents. Except

for such 6,954,322 shares, FMC-AG does not know or have reason to know that its bearer

Preference Shares are held by US. residents. Because the unidentified shares are bearer

shares, under Securities Act Release Nos. 33-7759 ( the "Cross-Border Release"), FMC-AG

may treat the holders of the unidentified shares as held by persons other than United States

residents. (Cross-Border Release, footnote 75.) After exclusion of preference shares held by

James A. Brigagliano, Esq

Mauri L. Osheroff, Esq.

Brian V. Breheny, Esq.

Michael Pressman. Esq.

January 13.2006

NYCDMS1969970.11

Page 5

the 10% holders, the 6,954,322 Preference Shares identified as held by U.S. residents

represent approximately 28.4% of FMC-AG's outstanding Preference Shares at December 5,

2005, as a result of which Tier IT relief is available.

4.

Surnrnarv of the Terms of the Offers

As described above, the Company has structured the Conversion Offers as two separate

offers -the U.S. Offer and the German Offer. Solicitation of conversions of Preference

Shares ADSs and conversions of Preference Shares held by U.S. residents will be made by

means of the prospectus included in the Registration Statement. The U.S. Offer is structured

to be conducted in accordance with U.S. federal securities laws, including Rule 13e-4 and

Regulation 14E, except to the extent of any exemptive relief granted pursuant to this letter,

as well as in accordance with applicable German law and regulations. The German Offer

will be made in accordance with applicable laws and regulations of Germany, including the

German Securities Sales Prospectus Act and will be made in accordance with a prospectus

that will be reviewed and approved by the BaFin. However, under German law, the

Conversion is considered to be an internal restructuring transaction between the Company

and its shareholders rather than a takeover bid, and the German Takeover Code does not

apply to the Conversion. The following summarizes other terms of the Conversion Offers:

Financial Terms: The Conversion Offers will be made on the.same financia1terms

- one Preference Share may be converted into one Ordinary Share upon tender of

such Preference Share plus a conversion premium of €9.75 per share. One

Preference Share ADS, which represents one-third of a Preference Share, may be

converted into one Ordinary Share ADS, representing one-third of an Ordinary

Share, upon tender of such ADS plus a conversion premium of €3.25 per share.

* Conditions to Consummation: The Company's obligation to complete the

Conversion Offers is not subject to the conversion of a specified minimum number

of Preference Shares. Completion of the Conversion Offers is subject to the

satisfaction or waiver of the condition that the Company is satisfied that the

Transformation will be registered with the commercial register immediately

following registration of the Conversion. Any waiver of or determination not to

waive a condition precedent will apply to both offers. As a result, assuming all

conditions are satisfied or waived, the Company will not complete one offer without

completing the other. Should a condition not be satisfied, the Company will not

terminate one offer without also terminating the other. If the Conversion Offers are

not completed successfully, tendered preference shares and conversion premiums

will be returned to tendering holders promptly following announcement of

termination of the Conversion Offers.

James A. Brigagliano, Esq

Mauri L. Osheroff. Esq.

Brian V. Breheny, Esq.

Michael Pressman. Esq.

January 13,2006

NYCDMSl969970.11

Page 6

0

Duration; fitension; Amendment: The commencement and expiration dates of the

U.S. Offer and the German Offer will be the same. As indicated above, the

Conversion is not subject to the German Takeover Code, and the Conversion Offers

are not subject to that Code's maximum duration provisions. The Company will

notify Preference shareholders of any amendment or extension of the Conversion

Offers by the issuance of an announcement or press release under German law and a

press release in the United States, and will file an amendment to its Schedule TO to

reflect such amendment or extension. If an amendment constitutes a material

change in the terms of the offers, the U.S. Offer will remain open for the applicable

period required by Rule 13e4(e)(3). The Conversion Offers will be open to all

Preference shareholders and, because the Company is obligated to conduct the

Conversion Offers on the terms approved by its shareholders on August 30, there

will be no changes in the consideration offered (one Ordinary Share for one

Preference Share plus €9.75; one ordinary ADS for one preference ADS plus €3.25)

or the percentage of Preference Shares sought.

Acceptance of the Conversion Offers. In general, holders of Preference Shares

(other than FMC-AG Preference Shares represented by ADSs) will accept the

Conversion Offers by notifying the appropriate authorized bank, financial

institution, custodian, brokerage or other intermediary at which such holders

maintain accounts for FMC-AG Preference Shares ("Intermediaries7'), at any time

prior to expiration of the Conversion Offers, of the holder's desire to tender and

completing transmittal materials provided by such Intermediary. Holders of FMCAG Preference Share ADSs will accept the U.S. Offer by delivering to the ADS

exchange agent their ADSs together with an executed Letter of Transmittal, any

other documents required by such letter, and the applicable conversion premium, or

by notifying the Intermediary through which they hold their Preference Share ADSs.

e

Subsequent OfSering Period. The Company does not intend to provide.a subsequent

offering period.

e

Withdrawal Rights. Holders of Preference Shares participating in the U.S. Offer will

have withdrawal rights as required by the Exchange Act and the rules and

regulations thereunder. Although German law does not require the Company to

provide withdrawal rights to participants in the German Offer, the Company has

nevertheless determined to provide withdrawal rights in the German offer.

James A. Brigagliano, Esq

Mauri L. Osheroff, Esq.

Brian V. Breheny. Esq.

Michael Pressman, Esq.

January 13, 2006

NYCDMS1969970.11

Page 7

5.

Discussion and Relief Requested

A.

Rule 13e-4ff)(8Xi): Inclusion of all ADS holders. wherever located. in the

U.S. Offer

The Conversion Offers have been structured to permit U.S. holders of the Company's

Preference Shares to participate in the transaction through the U.S. Offer on terms at least as

favorable as the German Offer.

The U.S. Offer will be open to all holders of FMC-AG Preference Share ADSs, wherever

located, and to holders of FMC-AG Preference Shares who are located in the United States,

and the German Offer will be open to holders of FMC-AG Preference Shares (other than

Preference Shares represented by ADSs) who are located in Germany or who are located

outside of Germany and the United States if, pursuant to the local laws and regulations

applicable to such holders, they are permitted to participate in the German Offer.

Rule 13e-4(f)@)under the Exchange Act provides that no person shall make an issuer tender

offer unless the offer is open to all security holders of the class of securities subject to the

issuer tender offer (the "All Holders Rule"). Rule 13e-4(i)(2)(ii) provides an exemption

from this provision and allows a bidder that qualifies for Tier 11relief to separate its offer

"into two offers: one offer made only to U.S. holders and another offer made only to nonU.S. holders" (emphasis added). It is a condition of this relief that the "offer to U.S. holders

must be made on terms at least as favorable as those offered any other holder of the same

class of securitiesthat is the subject of the tender offer."

Notwithstanding the Company's eligibility for Tier II relief, literal application of Rule 13e4(i)(2)(ii) would not exempt the dual offer structure described herein from the application of

the All Holders Rule because that Rule contemplates a U.S. offer that is made only to U.S.

holders and another that is made only to non-U.S. holders. Here, the U.S. Offer is made to

U.S. holders of FMC-AG Preference Shares (other than shares represented by ADSs) and to

all holders of FMC-AG Preference Share ADSs, wherever located.

We do not believe that this technical difference should disqualify the Conversion Offers

from the exemption available under Rule 13e-4(i)(2)(ii). The German Offer will be made

"only to non-U.S. holders." Any U.S. holder of any FMC-AG Preference Shares, including

U.S. holders of ADSs (as well as some non-U.S. holders of ADSs) will be tendering in an

offer that is conducted in accordance with the Exchange Act. No FMC-AG Preference

Shares held by U.S. holders will be converted except in response to the U.S. Offer, which

will be conducted in accordance with the US. federal securities laws, including Rule 13e-4

and Regulation 14E under the Exchange Act, except to the extent of any exemptive relief

granted pursuant to this letter. Participation in the U.S. Offer also is the most convenient

way for all ADS holders to participate in the Conversion Offers, since they will tender their

James A. Brigagliano, Esq

Mauri L. Osheroff, Esq.

Brian V. Breheny, Esq.

Michael Pressman, Esq.

January 13,2006

NYCDMS1969970.I1

Page 8

ADSs directly to the ADS exchange agent appointed by the Company. We note that the

Staff has permitted other similar dual offer structures involving U.S. offers made for both

shares held by U.S. holders and for ADSs held by holders, wherever located, including in

cases where the Tier 11 exemption under the Commission's tender offer rules was not

available due to the level of U.S. ownership. See Ofkr by SanoP-Synthdabofor any and all

ordinary shares, including ordinary shares represented by ADSs, of Aventis (June 10,2004)

(hereafter, Sanoj-Synthklabo No-Action ~etter)';W e r by Alcan, Inc. for Common Shares,

ADSs, Bonm AIZocation Rights and O C W S of Pechiney (Oct. 8,2003) (hereafter,

Alcdechiney No-Action Letter);Serono S.A. W e rfor All Outstanding Ordinary

Shares, ADSs, OCEANEs and Warrants of Genset (Sept. 12,2002) (hereafter,

Serono/Genset No-Action Letter); Saipem SpA W e rfor Shares and ADSs of Bouygues

Offshore S.A. (July 29,2002); Proposed Exchange O@er by Technip, S.A.,for all of the

outstanding ordinary shares and American Depositary Shares of Coflexip, S.A. (Aug. 30,

2001) (hereafter, Technip/Cojlex@No-Action Letter);In the Matter of the Exchange OfSer by

Banco Bilbao VizcayaArgentaria, S.A.for ordinary shares and American Depositary Shares

ofBBVA Banco Frances (Apr. 19,2001) (hereafter, Banco Bilbao VizcayaArgentaria S.A.

No-Action Letter).

Accordingly, on behalf of FMC-AG, we respectfully request exemptive relief under Rule

13elt(f)@)(i) to permit the Conversion Offers to be conducted according to the dualsffer

structure described in this letter (i.e., with the U.S. Offer being extended to all holders of

preference share ADSs, wherever located), notwithstanding that read literally Rule 13e4(i)(2)(ii) contemplates Tier 11 exemptive relief only for a dual offer structure in which one

offer is made "only" to U.S. holders and "another offer" is made only to non-U.S. holders.

B.

Rule 14e-5: Purchases (Conversions) Outside U.S. Offer

Rule 14e-5 under the Exchange Act prohibits an issuer or its affiliate making a tender or

exchange offer for an equity security from, directly or indirectly, purchasing or making any

arrangement to purchase such security or any security which is immediately convertible into

or exchangeable for such security except pursuant to such offer. The prohibition on

purchases outside the offer under Rule 14e-5 continues from the time of the public

announcement of the offer until expiration of the offer, including any extensions thereof.

The Rule provides an express exception for purchases or arrangements to purchase in crossborder issuer tender offer excepted under Rule 13e-4(h)(8), which requires that less than

10% of the subject securities are held by U.S. holders and that certain other conditions have

been met. See Rule 14e-5@)(10). Rule 14e5 does not provide a comparable exemption for

cross-border tender offers that qualifl for Tier 11treatment under Rule 13e-4(i)(l)(ii).

However, pursuant to Rule 14e-5(d), upon written application or upon its own motion, the

The Sanofi-SynthklaboNo-Action Letter also granted relief where there were three offers made

under Rule 13e-4(i)(2)(ii)- a U.S. offer, a French offer and a German offer, but all ADS holders

participated in the U.S. offer.

James A. Brigagliano, Esq

Mauri L. Osheroff, Esq.

Brian V. Breheny, Esq.

Michael Pressman, Esq.

January 13,2006

NYCDMS1969970.11

Page 9

Commission may grant an exemption &om the provisions of Rule 14e-5. The Company is

not requesting any relief under Rule 14e-5 other than the relief required to '%purchase"

Preference Shares pursuant to the German Offer while the U.S. Offer is pending.

A literal application of Rule 14e-5 could be interpreted to prohibit conversions of FMC-AG

Preference Shares pursuant to the German Offer after the announcement of the U.S. Offer.

Notwithstanding that a dual offer structure is expressly contemplated and permitted under

the Tier I1 Relief provided by Rule 13e-4(2)(i), we understand it to be the Commission's

position that an individual exemption from Rule 14e-5 may still be needed for a dual offer

structure. See, e.g., Manual of Publicly Available Telephone Interpretations, Third

Supplement, Regulation M-A, Part L. Rule 14e-5, Question 3 (SEC Division of Corporation

Finance, July 2000).

.

A s required in order to qualify for Tier I1 relief, holders of FMC-AG Preference Shares who

are located in the United States will be entitled to participate in the U.S. Offer on economic

terms as favorable as those offered to holders of FMC-AG Preference Shares in the German

Offer. The Company has taken steps to ensure (i) that the procedural terms of the Offers

will be as equivalent as practicably possible, given the considerations of local law and

customary local practice, and (ii) that the consideration in the Offers will be the same, except

that in order to tender their shares for conversion, U.S. holders must tender the conversion

premium in a sufficient amouwt of U.S. dollars to pay the conversion premium in euro at the

then-prevailing current exchange rate.

Assuming that the Conversion Offers will result in purchases of Preference Shares by the

Company during the period in which such purchases are prohibited by Rule 14e-5,6 the only

offers to purchase and the only purchases of FMC-AG Preference Shares by the Company

that are made outside the U.S.Offer will be made pursuant to the German Offer. Because

the proposed dual offer structure involves purchases pursuant to a foreign tender offer, it

does not present the same risks as would open market or private purchases, q d we believe

that the poIicies forming the basis for Rule 14e-5 will not be violated if the exemption

requested is granted. Moreover, the Company's intention to conduct the German Offer and

to make "purchases" pursuant to the German Offer is fully disclosed in the Prospectus to

holders of FMC-AG Preference Shares and, pursuant to the U.S. Offer, holders who tender

Unlike a conventional tender offer or even a conventional exchange offer, the Company will not

reacquire Preference Shares to be converted. Such shares will not be surrendered to the Company or

"exchanged" for Ordinary Shares or held as treasury shares after completion of the Conversion Offers.

Rather, by operation of German law, tendered Preference Shares will be converted into and will

become Ordinary Shares. There will be no change in the aggregate Ordinary Shares and Preference

Shares outstanding after the Conversion - instead, the number of Ordinary Shares will increase and

the number of Preference Shares will decrease due to the Conversion. While we are not relying on

this argument to justify the Company's request for exemptive relief, it could be argued that, in fact,

the Company is not purchasing any shares during the restricted period.

James A. Brigagliano, Esq

Mauri L. Osheroff, Esq.

Brian V. Breheny, Esq.

Michael Pressman, Esq.

January 13,2006

NYCDMSl969970.11

Page 10

in the U.S. Offer will be entitled to receive the same consideration upon conversion as will

be received pursuant to conversions under the German Offer.

We believe that the exemptive relief requested in this letter is consistent with the dual offer

structure expressly permitted by the Tier I1 Relief provided by Rule 13e-4(i). Relief under

Rule 14e-5 has specificallybeen granted in connection with issuer tender offers conducted

by foreign issuers as dual offers. See AB Electrolux (May 12,2004).

Accordingly, on behalf of the company, we hereby respectfully request exernptive relief .

pursuant to Rule 14e-5(d) from the provisions of Rule 14e-5 with regard to conversions of

FMC-AG Preference Shares pursuant to the German Offer.

C.

Rule 13e-4(fl(6): Purchases (Conversions) Outside U.S. Offer

Like Rule 14e-5, R U G 13e-4(fH6) also prohibits an issuer conducting a tender offer from

purchasing, other than pursuant to the tender offer, any security that is the subject of the

tender offer or any right to purchase such security and, in an issuer exchange offer, any

security that is offered in the exchange offer or any right to purchase such security. The

prohibition under Rule 13e-4(f)(6) extends until the expiration of 10 business days following

expiration of the tender offer. While not expressly referenced in the Telephone

Interpretations Manual discussion of Rule 14e-5 cited in part 5B above, it appears that the

Commission's position as to the need for exemptive relief is equally applicable under Rulk

l3e-4(6)@)?

We believe that the same considerations that support our request for relief under Rule 14e-5

also support the request under Rule 13e-4(f)(6). Both rules are intended to prevent

manipulative and deceptive practices in tender offers whereby an issuer purchases or

arranges to purchase shares outside of a tender offer - either during the offer or promptly

following its completion. Those practices include artificially increasing the price of a

company's stock, avoiding proration rules, taking advantage of the market's response to a

tender offer and offering different prices. We believe that the potential for such abuses is not

present in connection with the Company's Conversion Offers. As indicated above, the U.S.

Offer is being made on terms no less favorable than those offered in the German Offer. The

offers are being made on the same economic terms to all shareholders. The offers will be

made for the same period, and completion of both offers is subject to the same conditions.

The only "purchases" outside the U.S. Offer are those to be made in the German Offer.

Such "purchases" will not enable the Company to avoid proration requirements, since the

U.S.and German Offers are, in the aggregate, open to all holders of the Company's

preference shares, so that there will be no proration of shares submitted for conversion. As a

result, "purchases" in the German Offer will effectively be made on the same economic and

The possible need for such relief was expressly raised in the Staffs comments on Amendment No. 1

to the Registration Statement.

James A. Brigagliano, Esq

Mauri L. Osheroff, Esq.

Brian V. Breheny. Esq.

Michael Pressman, Esq.

January 13,2006

NYCDMS1969970.11

Page 1I

other terms and conditions as those in the U.S. Offer, avoiding the manipulative effects

targeted by both rules.

Relief under Rule 13e-4(f)(6) for purchases of securities in dual offers such as the

Company's Conversion Offers has also specifically been granted in combination with a

request for similar relief under Rule 14e5. See Compania Anonima Nacional Telefonos de

Venezuela (CANiTJ (November 20,2001); E.I. Du Pont de Nernours and Cornpany/Conoco

Inc. (June 17, 1999) (Grant of exemption under Rule lob-1 3 for issuer's purchases of shares

in a cash offer made to non-U.S. shareholders during the pendency of an exchange offer

made to U.S. shareholders)? Such relief also appears to be consistent with the exemptive

relief granted under Rule 14e-5 in connection with third party tender offers similarly

structured as dual offers, including some dual offers that did not qualify for Tier II Relief.

See AB Electrolm, supra; Sanofi-Synthdabo No-Action Letter; A l c d e c h i n e y No-Action

-Letter, supra; Serono/Genset No-Action Letter, supra; Technip/Coflexip No-Action Letter,

supra; Banco Bilbao Vizcaya Argentaria S.A. No-Action Letter, supra; In the Matter of

TotalFina S.A.. fichange W e rfor Securities of ElfAquitaine (July 2 1, 1999) (granted

pursuant to former Rule 10b-13, the predecessor rule to Rule 14e-5).

In connection with this request under Rule 13e-4(f)(6), the Company confirms that it is not

seeking any relief other than relief required to "purchase" preference shares pursuant to the

German Offer while the U.S. Offer is open and will otherwise comply with the restrictions of

Rule 13e-4(f). Accordingly, on behalf of the Company, we hereby respectfully request

exemptive relief fiom the provisions of Rule 13e-4(f)(6) with regard to conversions of FMCAG Preference Shares pursuant to the German Offer.

The Registration Statement was declared effective on January 4,2006, and the U.S. Offer

commenced on January 6,2006 by the mailing of the prospectus to holders of ADSs

representing Preference Shares and U.S. holders of Preference Shares.

Should you have any questions or require additional information, please contact the

undersigned at 212 891-3587 or Charles F. Niemeth at 212 891-3586.

Thank you very much for your consideration of this request.

Indeed, in the two cited letters, neither the request for relief and related discussion of Rules 1%4(f)(6) and Rule 14e-5 nor the grant of relief separately considered or analyzed the two rules.

James A. Brigagliano, Esq

Mauri L. Osheroff, Esq.

Brian V. Breheny, Esq.

Michael Pressman, Esq.

January 13.2006

NYCDMS1969970.11

Page 12